PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

FLSHclust, a new algorithm, reveals rare and previously unknown CRISPR-Cas systems

2023-11-23
(Press-News.org) Using a new algorithm called FLSHclust (“flash clust”), researchers have discovered 188 rare and previously unknown CRISPR-linked gene modules – including a novel type VII CRISPR-Cas system – among billions of protein sequences. The approach and its findings provide novel opportunities for harnessing CRISPR systems and understanding the vast functional diversity of microbial proteins. CRISPR systems have been leveraged to develop a growing suite of novel biomolecular approaches, including CRISPR/Cas-mediated genome editing. The discovery of previously unknown CRISPR systems has the potential to lead to the further development of these biotechnologies, including safer and more effective genomic therapeutics. The CRISPR toolbox has been expanded through computational searches of protein sequence databases. However, the algorithmic approaches commonly used have become impractical for mining exponentially growing datasets containing billions of proteins. To address this limitation, Han Altae-Tran and colleagues developed FLSHclust (fast locality-sensitive hashing-based clustering) – an algorithm for clustering proteins by sequence similarity, which, unlike currently available methods, can quickly and efficiently analyze vast protein sequence databases. To evaluate their approach, Altae-Tran et al. used FLSHclust to search for rare CRISPR systems in an 8.8 terrabase pair metagenomic database containing 8 billion proteins and 10.2 million CRISPR arrays. The analysis uncovered 188 previously unknown CRISPR-associated genes. The authors also identified and characterized a new class of Cas-14 containing CRISPR system, type VII, which acts on RNA. According to the findings, the newly identified systems were rare, and many only encompassed a single cluster out of the nearly 130,000 CRISPR-linked clusters revealed by FLSHclust. “The discovery of previously unknown cas genes and CRISPR systems substantially expands the known CRISPR diversity, emphasizing the functional versatility of CRISPR whereby previously undiscovered proteins and domains are often recruited, either replacing preexisting components or conferring newly identified functions to the preexisting scaffold of Cas proteins,” write Altae-Tran et al. “Taken together, the results of the work reveal unprecedented organizational and functional flexibility and modularity of CRISPR systems but also demonstrates that most variants are rare and only found in relatively unusual bacteria and archaea.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Extremely energetic cosmic ray detected, but with no obvious source

2023-11-23
An extremely energetic cosmic ray – an extragalactic particle with an energy exceeding ~240 exa-electron volts (EeV) – has been detected by the Telescope Array experiment’s surface detector, researchers report. However, according to the findings, its arrival direction shows no obvious source. Ultrahigh-energy cosmic rays (UHECRs) are subatomic charged particles from space with energies greater than 1 EeV – roughly a million times as high as the energy reached by human-made particle accelerators. Although low-energy cosmic rays primarily emanate from the sun, the origins of rarer UHECRs are thought to be related to the most energetic phenomena in the Universe, ...

Telescope Array detects second highest-energy cosmic ray ever

Telescope Array detects second highest-energy cosmic ray ever
2023-11-23
In 1991, the University of Utah Fly’s Eye experiment detected the highest-energy cosmic ray ever observed. Later dubbed the Oh-My-God particle, the cosmic ray’s energy shocked astrophysicists. Nothing in our galaxy had the power to produce it, and the particle had more energy than was theoretically possible for cosmic rays traveling to Earth from other galaxies. Simply put, the particle should not exist.  The Telescope Array has since observed more than 30 ultra-high-energy cosmic rays, though none approaching the Oh-My-God-level energy. No observations have yet revealed ...

'Dolomite Problem': 200-year-old geology mystery resolved

2023-11-23
Images // Video ANN ARBOR—For 200 years, scientists have failed to grow a common mineral in the laboratory under the conditions believed to have formed it naturally. Now, a team of researchers from the University of Michigan and Hokkaido University in Sapporo, Japan have finally pulled it off, thanks to a new theory developed from atomic simulations. Their success resolves a long-standing geology mystery called the "Dolomite Problem." Dolomite—a key mineral in the Dolomite mountains in Italy, Niagara Falls, the White Cliffs of Dover and Utah's Hoodoos—is very abundant in rocks older than 100 million years, but nearly absent in younger ...

AI recognizes the tempo and stages of embryonic development

2023-11-23
Animal embryos go through a series of characteristic developmental stages on their journey from a fertilized egg cell to a functional organism. This biological process is largely genetically controlled and follows a similar pattern across different animal species. Yet, there are differences in the details – between individual species and even among embryos of the same species. For example, the tempo at which individual embryonic stages are passed through can vary. Such variations in embryonic development are considered an important driver of evolution, as they can lead to new characteristics, thus promoting evolutionary adaptations and biodiversity. Studying the embryonic ...

Potential new target and drug candidate for Barth syndrome

2023-11-23
In a Nature Metabolism paper published today, researchers from the University of Pittsburgh detail a potential new target and a small-molecule drug candidate for treating Barth syndrome, a rare, life-threatening and currently incurable genetic disease with devastating consequences. Barth syndrome affects about 1 in every 300,000 to 400,000 babies born worldwide. Those with the condition have weak muscles and hearts and experience debilitating fatigue and recurrent infections. Pitt researchers discovered that faulty mitochondria are at least partially to blame, and identified a molecular culprit that could be targeted to potentially reverse the disease course in the future. In ...

New therapy can treat rare and hereditary diseases

New therapy can treat rare and hereditary diseases
2023-11-23
A lot of research has been done over many decades on diseases that are widespread in large parts of the population, such as cancer and heart disease. As a result, treatment methods have improved enormously thanks to long-term research efforts on diseases that affect many people. However, there are many diseases that affect just a handful people. These diseases often fly under the radar and are far less researched. They include quite a few rare, hereditary diseases, such as DOOR syndrome, which is ...

Y-chromosome and its impact on digestive diseases

2023-11-23
A major breakthrough in human genetics has been achieved with the complete decoding of the human Y chromosome, opening up new avenues for research into digestive diseases. This milestone, along with advancements in third-generation sequencing technologies, is poised to revolutionize our understanding of the genetic underpinnings of digestive disorders and pave the way for more personalized and effective treatment strategies. The Y chromosome, the smallest of the human chromosomes, has long been shrouded in mystery due to its complex repetitive structure. However, recent advancements in sequencing technologies have enabled researchers to unravel the intricate details of this genetic ...

Fractional COVID-19 booster vaccines produce similar immune response as full-doses

2023-11-23
Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study. The research, led by Murdoch Children's Research Institute (MCRI) and the National Centre for Communicable Diseases in Mongolia, found that a half dose of a Pfizer COVID-19 booster vaccine elicited a non-inferior immune response to a full dose in Mongolian adults who previously had AstraZeneca or Sinopharm COVID-19 shots. But it found half-dose boosting may be less effective in adults primed with the Sputnik V COVID-19 vaccine.  The research ...

Consolidator Grants: ERC unleashes €627 million in grants to fuel excellent research across Europe

2023-11-23
Iliana Ivanova, European Commissioner for Innovation, Research, Culture, Education and Youth, said: “I extend my heartfelt congratulations to all the brilliant researchers who have been selected for ERC Consolidator Grants. I'm especially thrilled to note the significant increase in the representation of women among the winners for the third consecutive year in this prestigious grant competition. This positive trend not only reflects the outstanding contributions of women researchers but also highlights the strides we are making towards a more inclusive and diverse scientific community.”  President of the European Research Council Prof. Maria Leptin said: “The new ...

A fifth higher: Tropical cyclones substantially raise the Social Cost of Carbon

2023-11-23
Extreme events like tropical cyclones have immediate impacts, but also long-term implications for societies. A new study published in the journal Nature Communications now finds: Accounting for the long-term impacts of these storms raises the global Social Cost of Carbon by more than 20 percent, compared to the estimates currently used for policy evaluations. This increase is mainly driven by the projected rise of tropical-cyclone damages to the major economies of India, USA, China, Taiwan, and Japan under global warming. “Intense tropical cyclones have the power to slow down the economic development of a country for more than a decade, our analysis shows. With global warming, the share ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] FLSHclust, a new algorithm, reveals rare and previously unknown CRISPR-Cas systems